ArticleNature2021
Omicron-variant border bans ignore the evidence, say scientists.
Article in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Geographies of biosecurity: Racialized vulnerability, colonial extraction, and a new critical consciousness.Progress in human geography · 2026Article
- Health security-Why is 'public health' not enough?Global health research and policy · 2025Article
- Beyond "business as usual": lessons from FIFA for fair benefit-sharing in global health.Health affairs scholar · 2024Article
- COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2.Current genomics · 2024Review
- Data Sharing During Pandemics: Reciprocity, Solidarity, and Limits to Obligations.Journal of bioethical inquiry · 2023Article
- The importance of utilizing travel history metadata for informative phylogeographical inferences: a case study of early SARS-CoV-2 introductions into Australia.Microbial genomics · 2023Article
- Importation of Alpha and Delta variants during the SARS-CoV-2 epidemic in Switzerland: Phylogenetic analysis and intervention scenarios.PLoS pathogens · 2023Article
- Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1.Science (New York, N.Y.) · 2023Article
- Review
- SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs.Nature genetics · 2023Article
- Ethics and governance challenges related to genomic data sharing in southern Africa: the case of SARS-CoV-2.The Lancet. Global health · 2022Review
- The Lancet Commission on lessons for the future from the COVID-19 pandemic.Lancet (London, England) · 2022Review
- The effects of air transport mobility and global connectivity on viral transmission: Lessons learned from Covid-19 and its variants.Transport policy · 2022Article
- SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs.medRxiv : the preprint server for health sciences · 2022Article
- Structural bioinformatics analysis of SARS-CoV-2 variants reveals higher hACE2 receptor binding affinity for Omicron B.1.1.529 spike RBD compared to wild type reference.Scientific reports · 2022Article
- COVID-19: Omicron - the latest, the least virulent, but probably not the last variant of concern of SARS-CoV-2.Microbial biotechnology · 2022Review
- Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic.Environmental research · 2022Review
- The use, misuse and overuse of the 'low-income and middle-income countries' category.BMJ global health · 2022Article
- Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions.Annals of medicine and surgery (2012) · 2022Review
- The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape.International journal of biological macromolecules · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
34857946What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.